# We built the autoinjector designed for how patients actually live | Sempresto

- Canonical URL: https://wefunder.com/feed/374536
- Entity ID: wefunder:feed_item:374536
- Published at: 2026-08-25 17:36:04 UTC
- Updated at: 2026-08-25 17:36:06 UTC

## Author
Elizabeth Reczek

## Subject
Sempresto

## Content
Sempresto's community round is now open, and you're getting first access to preferred early bird terms!Every year in the United States, people die from anaphylaxis who don't have to. The medication exists. The prescriptions are filled. The single biggest barrier to prompt treatment is a failure to carry an Epinephrine autoinjector. That is not a medical failure. It is a design failure.Sempresto is building a solution that fixes it. Our autoinjector attaches directly to a smartphone, the one thing people already carry everywhere. Slim enough for a pocket, simple enough to use in seconds, and connected to 24/7 emergency telehealth through our partner platform. Invented by the Chief Physician Executive at Jefferson Health, protected by 15 issued patents and 10 pending applications, and built for how patients actually live.Our traction to date:💰 $2.5M committed; Jefferson University strategic partner🏥 Invented by the Chief Physician Executive at Jefferson Health📱 Smaller than traditional autoinjectors; compatible with 95% of phones📈 $3B+ US addressable market; 33M Americans with food allergies🔬 15 issued patents, 10 pending🎯 FDA filing targeted within 18 months; no clinical trials required👥 Team behind 3 IPOs and 30+ business development transactionsThis round is open to our community first - early investors have priority access to discounted terms before we open to the public.Invest now → wefunder.com/semprestoElizabeth Reczek, PhDCo-Founder & CEOSempresto